Ph.D., CEO, Director of Scientific Affairs, Cancer Research Institute (CRI)
Jill O’Donnell-Tormey, Ph.D., is Chief Executive Officer and Director of Scientific Affairs of the Cancer Research Institute, a nonprofit organization founded in 1953 that is today the global leader in supporting and coordinating research aimed at harnessing the immune system’s power to conquer all cancers. She joined the organization in 1987, and has been Chief Executive since 1993. Prior to joining CRI, she served as a research associate in the department of medicine at Cornell University Medical College and as a postdoctoral fellow in the laboratory of cellular physiology and immunology at The Rockefeller University.
Immunotherapy Showcase: Assessing the Immuno-Oncology Landscape: Challenges and Opportunities in Cancer Research
The Cancer Research Institute (CRI) has been supporting cancer immunology (IO) research from bench to bedside for 65 years with the world’s most prominent IO network and awarding nearly $360 million in research funding. CRI CEO, Jill O’Donnell-Tormey, shares her expertise on cancer immunotherapy, current opportunities and challenges, and her thoughts on the field’s future direction. Jill will share data from CRI’s recently published Immunotherapy landscape analysis which point to challenges from research inefficiencies to clinical trial recruitment and why it is a critical time to fund research and collaborate across the industry.